Rindopepimut: an evidence-based review of its therapeutic potential in the treatment of EGFRvIII-positive glioblastoma.

Core Evid · 2012 · PMC3459544 · PMID 23055947

Europe PMC DOI

hedged sentence

0.0830

closest p · 1.7× alpha

0.0830

boldest claim

The sentences

did not reach statistical significanceP = 0.083so close (0.05 < p ≤ 0.1)

While this difference did not reach statistical significance ( P = 0.083), the results may have been negatively biased as EGFRvIII expression was not a criterion for inclusion.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.